Liko FreeSpan Traverse & FreeSpan Ultra Twin Traverse Freestanding Lift Systems

Notice type: Advisory

Date: 25/02/2014

 

Product name or type:
Liko FreeSpan Traverse & FreeSpan Ultra Twin Traverse Freestanding Lift Systems


Reference:
SN2014(07)


Manufacturer Or Supplier:
Liko / Hill-Rom


Target Audience:
General Public 
Hospital CEOs 
Risk Managers 
Procurement Managers 
Loan Store Managers 
Clinical Engineers 
HSE Offices 
Community Care Centres 
Occupational Therapists 
Community Care Managers 
Community Therapists 
Health Visitors 
Carers 
Educational Establishments


Problem Or Issue:
Hill-Rom has identified that information in the instructions guide dated the 7th November 2007 and earlier for the FreeSpan Traverse & FreeSpan Ultra Twin Traverse Freestanding Lift Systems is not clear regarding maximum overhang allowed for the systems.


Background Information Or Related Documents:
Hill-Rom is informing users that when assembled, the system is not designed to have an overhang greater than 300mm (11.8 inches). If the overhang is greater than 300mm (11.8 inches), there is a risk for the system to tip over. This information was not clear in the instructions (3EN110750-01 thru - 04) shipped prior to the 7th November 2007. Systems sold after the 7th November 2007 are not affected by this issue. 

This field safety corrective action has been ongoing since July 2012. Hill-Rom has been unsuccessful in their attempts to date to locate all devices in Ireland affected by this field safety corrective action. There are four affected lifting systems on the Irish market, which cannot be located. These products were supplied to the Irish market by KCI Medical, who are no longer a distributor for these products. 

The IMB has not received any complaints in relation to this issue. Full details of the field safety corrective action can be found in the attached field safety notice issued by Hill-Rom.

Liko FreeSpan TraverseFreeSpan Ultra Twin Traverse Freestanding Lift Systems Document


Actions To Be Taken:
The IMB advises that users: 

(1) The IMB recommends that users forward this safety notice to all those who need to be aware of this action within your organisation, including those who maintain lifting systems and to any other persons/organisations where these devices have been transferred. 

(2) Identify the location of all affected lifting systems. 

(3) If you / your institution have any affected lifting systems, please follow the manufacturer’s recommendations as outlined in the attached field safety notice and examine the set-up of the lifting system. 


Further Information:
Enquries: 

Enquiries to the manufacturer should be addressed to: 

Marlene Bjurman 
Hill-Rom Liko Luleå 
Nedre Vägen 100 
97592 Luleå 
Sweden 

Telephone: +46-920-47-47-00 
Fax: +46-920-47-47-01 
Email: se.quality@hill-rom.com 

All adverse incidents relating to a medical device should be reported to the: 

Health Products Regulatory Authority
Kevin O’Malley House 
Earlsfort Centre 
Earlsfort Terrace 
Dublin 2 

Telephone: +353-1-6764971 
Fax: +353-1-6344033 
E-mail: devicesafety@hpra.ie
Website: www.hpra.ie

Please click here to view a copy of the field safety notice

Please click here to view a PDF version of the safety notice


« Back